目的研究胃癌术后腹腔热灌注化疗联合静脉化疗的治疗效果。
Objective:To study the effect of intraperitoneal hyperthermic perfusion chemotherapy combined with venoclysis on postoperative gastric cancer.
对照组30例单纯采用顺铂使用体腔热灌注机腹腔热灌注化疗。
The control group of 30 patients were simply treated with peritoneal perfusion chemotherapy of cisplatin.
结论腹腔热灌注化疗能明显提高胃癌术后病人的生存率和生存质量。
Conclusion IPHP with chemotherapeutic agents can improve the survival rate and life quality of postoperative stomach cancer patients.
目的：观察腹腔热灌注化疗联合热疗治疗恶性腹水的疗效及其副反应。
Objective: To evaluate the effects and toxicities of the chemotherapeutic hyperthermic intraperitoneal perfusion(CHIP) combined with hyperthermia for the treatment of malignant ascites.
目的探讨HGGZ-102型体腔热灌注治疗机对犬腹腔热灌注化疗的安全性。
Objective The present study is to explore the safe of chemotherapeutic hyperthermic intraperitoneal perfusion by using the HGGZ-102 hyperthermic perfusion machine.
结论：在中晚期消化道肿瘤，尤其伴有腹水病人治疗中，采用持续腹腔热灌注化疗可明显提高治疗效果。
Conclusions: CHPP on patients with late digestive tract cancer, especially those patients followed by ascites, can evidently enhance the effectiveness of the treatment.
胃肠肿瘤术后低渗热灌注腹腔化疗预防腹腔复发的临床疗效。
Clinical Study on prevention of the postoperative gastrointestinal tumors from intraperitoneal relapse by intraperitoneal chemotherapy through hypothermal hypotonic perfusion.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
结论：应用康莱特联合顺铂热灌注化疗治疗恶性腹腔积液有一定的效果，值得推广应用。
Conclusion: the application of perfusion chemotherapy of kang-lai-te injection with cisplatin for malignant ascites. has a certain effect and should be widely applied.
结论：应用康莱特联合顺铂热灌注化疗治疗恶性腹腔积液有一定的效果，值得推广应用。
Conclusion: the application of perfusion chemotherapy of kang-lai-te injection with cisplatin for malignant ascites. has a certain effect and should be widely applied.
应用推荐